IRIS- DESyne X2 in the IRIS-DES Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorSeung-Jung Park
About this trial
This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 19 and more
Intervention with DeSyne X2 drug-eluting coronary stent
Agreed with written informed consent form
Disqualifiers
Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time
Life expectancy of 1year and under
Cardiac shock
Trial population
patients with DeSyne X2 stent
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
DESyne X2
DeviceNovolimus-eluting stent
Treatment groups
1,000 Participants
are divided into 1 treatment groupGroup A: Coronary stenosis1 intervention
Trial outcomes
Primary outcomes
1
Composite event rate
Death, non-fatal myocardial infarction, Target Vessel Revascularization
Time frame
1yearSecondary outcomes
1
All death
Time frame
5years2
Cardiac death
Time frame
5years3
Myocardial infarction
Time frame
5years4
Composite event of death or myocardial infarction
Time frame
5yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Seung-Jung Park
Lead sponsor
Asan Medical Center
Sponsor institution
CardioVascular Research Foundation, Korea
Collaborator
Source ClinicalTrials.gov